Autopsy report · NCT00965302
Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients
Cause of deathRegulatory or ethics
“Investigator did not submit an annual continuation report with the Institutional Review Board and the study was officially removed from IRB regulatory oversight on Sep 2014, based on 32 CFR 219.109e. The study officially expired/terminated.”
Life of this trial
- Ran for about 5 years 1 month before it stopped.
- 50 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- 59th Medical Wing
- Sponsor type
- US federal agency
- Conditions
- Diabetes Mellitus, Type 2; Obesity
- Interventions
- Laparoscopic sleeve gastrectomy; Intensive medical management
- Participants
- 50
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Adherence to Otezla
“Terminated IRB approval 6/26/2024, study was never initiated or activated” - A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
“The study was suspended by the IRB of record and subsequently terminated” - Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy
“The study expired at the IRB” - A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer
“The IRB which was overseeing the study stopped overseeing it” - Antibiotics and Tissue Expanders in Breast Reconstruction
“The study was withdrawn prior to IRB approval.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.